These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1356792)

  • 1. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA; Dzimiri N
    Eur J Pharmacol; 1992 May; 215(2-3):231-6. PubMed ID: 1356792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of procainamide, tocainide and phenytoin on guinea pig cardiac mitochondrial ATPase activity.
    Dzimiri N
    Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):121-4. PubMed ID: 8488338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of class I antiarrhythmic drugs on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA
    Gen Pharmacol; 1993 Jan; 24(1):233-7. PubMed ID: 8482500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta-adrenergic blockers on Na(+)-K(+)-ATPase activity in guinea-pig heart preparations: comparison with ouabain.
    Almotrefi AA; Dzimiri N
    Arch Int Pharmacodyn Ther; 1991; 310():94-101. PubMed ID: 1685314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the binding of beta-adrenoceptor blockers to microsomal Na+/K+-ATPase in guinea pig heart preparations.
    Almotrefi AA; Basco C; Moorji A; Dzimiri N
    Can J Physiol Pharmacol; 2001 Jan; 79(1):8-12. PubMed ID: 11201505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of indenolol on human airways.
    Zanon P; Bruschi C; Cerveri I; Rossi A; Karitinos P; Pamparana F
    Eur J Clin Pharmacol; 1985; 29(3):287-92. PubMed ID: 2866966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of amiodarone on mitochondrial ATPase and lactate dehydrogenase activities in guinea pig heart preparations.
    Dzimiri N; Almotrefi AA
    Eur J Pharmacol; 1993 Sep; 242(2):113-8. PubMed ID: 8253107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the beta-adrenoceptor that mediates the relaxant response to noradrenaline in guinea-pig tracheal smooth muscle.
    Tanaka Y; Yamashita Y; Michikawa H; Horinouchi T; Koike K
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):51-64. PubMed ID: 17237919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Membrane stabilizing actions of befunolol and indenolol, new beta-adrenergic receptor blocking drugs (author's transl)].
    Sada H; Harada S; Kojima M; Ban T
    Kokyu To Junkan; 1981 Nov; 29(11):1231-7. PubMed ID: 6121358
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardioselectivity of cetamolol compared with atenolol and nadolol.
    Klausner MA; Ventura DF; Coelho J; Mullane JF; Irwin C; Hitzenberger G; Magometschnigg D; Kaik G; Garg DC; Weidler DJ
    J Clin Pharmacol; 1988 Jun; 28(6):495-504. PubMed ID: 2901435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
    Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
    Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers and psychometric performance: studies in normal volunteers.
    McDevitt DG
    Eur J Clin Pharmacol; 1985; 28 Suppl():35-8. PubMed ID: 2865148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.